Rank 56 • Biotech & Discovery
Metagenomi
Deploys computational tools and metagenomics to discover and develop next-generation gene editing systems for therapeutics.
Visit website- Signal Score
- 85.1
- Total raised
- $300M
- Stage
- Public
- Founded
- -
- Headquarters
- Emeryville, USA
- Region
- North America
Their signal
Its deep library of novel nucleases and base editors, discovered through environmental metagenomics, offers a highly versatile toolbox for precise, curative genetic medicine.
Signal Score 85.1editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in Biotech & Discovery
Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.